We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
-14.6%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$68.5B
AUM Growth
-$9.16B
(-12%)
Cap. Flow
+$4.06B
Cap. Flow
% of AUM
5.93%
Top 10 Holdings %
Top 10 Hldgs %
21.45%
Holding
3,375
New
359
Increased
2,433
Reduced
285
Closed
282
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$124M |
| 2 |
Apple
AAPL
|
+$110M |
| 3 |
Microsoft
MSFT
|
+$104M |
| 4 |
Amazon
AMZN
|
+$71.3M |
| 5 |
Warner Bros
WBD
|
+$69.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AT&T
T
|
+$61.6M |
| 2 |
CERN
Cerner Corp
CERN
|
+$50.9M |
| 3 |
NXP Semiconductors
NXPI
|
+$31.4M |
| 4 |
AZPN
ASPEN TECHNOLOGY INC
AZPN
|
+$30.4M |
| 5 |
Yum China
YUMC
|
+$16.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.13% |
| 2 | Healthcare | 14.42% |
| 3 | Financials | 13.45% |
| 4 | Consumer Discretionary | 10.49% |
| 5 | Industrials | 9.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2376
AnaptysBio
ANAB
$1.68B
| $621K | ﹤0.01% |
30,597
+4,895
| +19% | +$108K |
|
|
DICE
2377
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
| $621K | ﹤0.01% |
40,022
+25,432
| +174% | +$437K |
|
2378
Financial Institutions
FISI
$821M
| $620K | ﹤0.01% |
23,846
+633
| +3% | +$17.6K |
|
2379
TETRA Technologies
TTI
$1.26B
| $620K | ﹤0.01% |
152,803
+33,448
| +28% | +$147K |
|
|
VXRT
2380
DELISTED
Vaxart
VXRT
| $620K | ﹤0.01% |
177,163
+48,327
| +38% | +$181K |
|
2381
indie Semiconductor
INDI
$854M
| $619K | ﹤0.01% |
+108,651
| New | +$748K |
|
|
PTVE
2382
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
| $618K | ﹤0.01% |
62,079
+12,605
| +25% | +$127K |
|
2383
i3 Verticals
IIIV
$342M
| $617K | ﹤0.01% |
24,652
+3,994
| +19% | +$101K |
|
2384
Gossamer Bio
GOSS
$87M
| $616K | ﹤0.01% |
73,650
-11,310
| -13% | -$87.6K |
|
2385
FuboTV Inc
FUBO
$273M
| $615K | ﹤0.01% |
20,747
+9,365
| +82% | +$436K |
|
|
ACCD
2386
DELISTED
Accolade Inc
ACCD
| $615K | ﹤0.01% |
83,125
+30,256
| +57% | +$265K |
|
|
AGEN
2387
Agenus
AGEN
$290M
| $613K | ﹤0.01% |
16,094
+4,836
| +43% | +$176K |
|
2388
Barrett Business Services
BBSI
$804M
| $613K | ﹤0.01% |
33,632
-4,804
| -12% | -$88.3K |
|
2389
Blend Labs
BLND
$386M
| $612K | ﹤0.01% |
+259,369
| New | +$970K |
|
|
DAWN
2390
DELISTED
Day One Biopharmaceuticals
DAWN
| $608K | ﹤0.01% |
33,954
+14,546
| +75% | +$150K |
|
2391
908 Devices
MASS
$364M
| $607K | ﹤0.01% |
29,490
+10,960
| +59% | +$184K |
|
2392
Boston Omaha
BOC
$436M
| $605K | ﹤0.01% |
29,280
+3,844
| +15% | +$84.2K |
|
2393
Holley
HLLY
$384M
| $605K | ﹤0.01% |
+57,582
| New | +$628K |
|
2394
SmartRent
SMRT
$272M
| $602K | ﹤0.01% |
+133,292
| New | +$673K |
|
2395
Upland Software
UPLD
$15.4M
| $602K | ﹤0.01% |
4,147
+1,247
| +43% | +$182K |
|
2396
Vishay Precision Group
VPG
$914M
| $602K | ﹤0.01% |
20,679
+1,855
| +10% | +$56.8K |
|
|
MOFG
2397
DELISTED
MidWestOne Financial Group
MOFG
| $601K | ﹤0.01% |
20,235
+2,456
| +14% | +$74.3K |
|
2398
Hyliion Holdings
HYLN
$690M
| $597K | ﹤0.01% |
185,273
+41,792
| +29% | +$147K |
|
2399
Sportsman's Warehouse
SPWH
$46M
| $596K | ﹤0.01% |
62,096
+18,531
| +43% | +$183K |
|
2400
Nkarta
NKTX
$172M
| $592K | ﹤0.01% |
48,031
+30,113
| +168% | +$395K |
|
Similar funds
VAM
RhumbLine Advisers's Q2 2022 Portfolio in Review
As of Q2 2022, RhumbLine Advisers held 3,375 positions worth $68.5B, down 12% from $77.7B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
RhumbLine Advisers deployed $4.06B of net new capital in Q2 2022, opening 359 new positions and adding to 2,433 existing holdings. Its largest new stake was Aspen Technology Inc: 81,883 shares worth $15M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was AT&T, an estimated $61.6M trimmed.
- RhumbLine Advisers's largest Q2 2022 buy was Aspen Technology Inc: 81,883 shares worth $15M.
- RhumbLine Advisers added most to Linde in Q2 2022, an estimated $124M increase.
- RhumbLine Advisers's biggest Q2 2022 reduction was AT&T, cutting an estimated $61.6M.
- RhumbLine Advisers fully exited Cerner Corp in Q2 2022, selling an estimated $50.9M.
- RhumbLine Advisers's ten largest holdings make up 21% of its $68.5B portfolio in Q2 2022.
- RhumbLine Advisers opened 359 new positions and closed 282 in Q2 2022.
- RhumbLine Advisers's portfolio value fell 12% quarter-over-quarter to $68.5B.
Based on RhumbLine Advisers's 13F filing for Q2 2022, filed 11 Aug 2022.